Menu
Back to Journals » OncoTargets and Therapy » Volume 11
Review
Reformulating acute myeloid leukemia: liposomal cytarabine and daunorubicin (CPX-351) as an emerging therapy for secondary AML
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 14,541 | Dovepress* | 9,059+ | 1,296 | 10,355 | |
| PubMed Central* | 5,482 | 852 | 6,334 | ||
| Totals | 14,541 | 2,148 | 16,689 | ||
| *Since 12 June 2018 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 2 |
View citations on PubMed Central and Google Scholar